Advances in and Perspectives on Transgenic Technology and CRISPR-Cas9 Gene Editing in Broccoli

被引:2
|
作者
Zhang, Li [1 ,2 ]
Meng, Sufang [1 ]
Liu, Yumei [1 ]
Han, Fengqing [1 ]
Xu, Tiemin [1 ,3 ]
Zhao, Zhiwei [3 ]
Li, Zhansheng [1 ,3 ]
机构
[1] Chinese Acad Agr Sci, Inst Vegetables & Flowers, State Key Lab Vegetable Biobreeding, Beijing 100081, Peoples R China
[2] Shanxi Agr Univ, Coll Hort, Taigu 030801, Peoples R China
[3] CAAS, Shouguang R&D Ctr Vegetables, Shouguang 262700, Peoples R China
关键词
broccoli; advances; gene editing; CRISPR-Cas9; Agrobacterium-mediated transformation; L; VAR; ITALICA; INTERGENERIC SOMATIC HYBRIDIZATION; CYTOPLASMIC MALE-STERILITY; PROSTATE-CANCER CELLS; BRASSICA-OLERACEA; DOWNY MILDEW; MOLECULAR CHARACTERIZATION; MEDIATED TRANSFORMATION; MESOPHYLL PROTOPLASTS; TRANSIENT TRANSFORMATION;
D O I
10.3390/genes15060668
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Broccoli, a popular international Brassica oleracea crop, is an important export vegetable in China. Broccoli is not only rich in protein, vitamins, and minerals but also has anticancer and antiviral activities. Recently, an Agrobacterium-mediated transformation system has been established and optimized in broccoli, and transgenic transformation and CRISPR-Cas9 gene editing techniques have been applied to improve broccoli quality, postharvest shelf life, glucoraphanin accumulation, and disease and stress resistance, among other factors. The construction and application of genetic transformation technology systems have led to rapid development in broccoli worldwide, which is also good for functional gene identification of some potential traits in broccoli. This review comprehensively summarizes the progress in transgenic technology and CRISPR-Cas9 gene editing for broccoli over the past four decades. Moreover, it explores the potential for future integration of digital and smart technologies into genetic transformation processes, thus demonstrating the promise of even more sophisticated and targeted crop improvements. As the field continues to evolve, these innovations are expected to play a pivotal role in the sustainable production of broccoli and the enhancement of its nutritional and health benefits.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Gene Editing in Trypanosomatids: Tips and Tricks in the CRISPR-Cas9 Era
    Yagoubat, Akila
    Corrales, Rosa M.
    Bastien, Patrick
    Leveque, Maude F.
    Sterkers, Yvon
    TRENDS IN PARASITOLOGY, 2020, 36 (09) : 745 - 760
  • [32] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Norton, Mary E.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (06) : 327 - 329
  • [33] Alzheimer disease mice improve with CRISPR-Cas9 gene editing
    Fyfe, Ian
    NATURE REVIEWS NEUROLOGY, 2019, 15 (05) : 247 - 247
  • [34] Gene Editing with Crispr-Cas9 for Treating Beta-Hemoglobinopathies
    Lee, Ciaran
    Bao, Gang
    Porteus, Matthew H.
    Cornu, Tatjana
    Miccio, Annarita
    Cradick, Thomas
    Cathomen, Toni
    Lundberg, Ante
    Mavilio, Fulvio
    BLOOD, 2015, 126 (23)
  • [35] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Haydar Frangoul
    四川生理科学杂志, 2020, 42 (04) : 506 - 506
  • [36] Gene Editing and Crop Improvement Using CRISPR-Cas9 System
    Arora, Leena
    Narula, Alka
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [37] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 252 - 260
  • [38] Reversible RNA acylation for control of CRISPR-Cas9 gene editing
    Habibian, Maryam
    McKinlay, Colin
    Blake, Timothy R.
    Kietrys, Anna M.
    Waymouth, Robert M.
    Wender, Paul A.
    Kool, Eric T.
    CHEMICAL SCIENCE, 2020, 11 (04) : 1011 - 1016
  • [39] Application of CRISPR-Cas9 gene editing for congenital heart disease
    Seok, Heeyoung
    Deng, Rui
    Cowan, Douglas B.
    Wang, Da-Zhi
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2021, 64 (06) : 269 - 279
  • [40] CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
    Fontana, Marianna
    Solomon, Scott D.
    Kachadourian, Jessica
    Walsh, Liron
    Rocha, Ricardo
    Lebwohl, David
    Smith, Derek
    Taubel, Jorg
    Gane, Edward J.
    Pilebro, Bjorn
    Adams, David
    Razvi, Yousuf
    Olbertz, Joy
    Haagensen, Alexandra
    Zhu, Peijuan
    Xu, Yuanxin
    Leung, Adia
    Sonderfan, Alison
    Gutstein, David E.
    Gillmore, Julian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (23): : 2231 - 2241